Global Transdermal Drug Patches Supply, Demand and Key Producers, 2023-2029

Global Transdermal Drug Patches Supply, Demand and Key Producers, 2023-2029

Page: 119

Published Date: 12 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Transdermal Drug Patches market size is expected to reach $ 7952.9 million by 2029, rising at a market growth of 1.8% CAGR during the forecast period (2023-2029).

Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

This report studies the global Transdermal Drug Patches production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Transdermal Drug Patches, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transdermal Drug Patches that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Transdermal Drug Patches total production and demand, 2018-2029, (M Pieces)
Global Transdermal Drug Patches total production value, 2018-2029, (USD Million)
Global Transdermal Drug Patches production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Pieces)
Global Transdermal Drug Patches consumption by region & country, CAGR, 2018-2029 & (M Pieces)
U.S. VS China: Transdermal Drug Patches domestic production, consumption, key domestic manufacturers and share
Global Transdermal Drug Patches production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Pieces)
Global Transdermal Drug Patches production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Pieces)
Global Transdermal Drug Patches production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Pieces)
This reports profiles key players in the global Transdermal Drug Patches market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem and Nitto Denko, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transdermal Drug Patches market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Pieces) and average price (USD/Piece) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Transdermal Drug Patches Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Transdermal Drug Patches Market, Segmentation by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Global Transdermal Drug Patches Market, Segmentation by Application
Rx Channel
OTC Channel

Companies Profiled:
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories

Key Questions Answered
1. How big is the global Transdermal Drug Patches market?
2. What is the demand of the global Transdermal Drug Patches market?
3. What is the year over year growth of the global Transdermal Drug Patches market?
4. What is the production and production value of the global Transdermal Drug Patches market?
5. Who are the key producers in the global Transdermal Drug Patches market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Transdermal Drug Patches Introduction
1.2 World Transdermal Drug Patches Supply & Forecast
1.2.1 World Transdermal Drug Patches Production Value (2018 & 2022 & 2029)
1.2.2 World Transdermal Drug Patches Production (2018-2029)
1.2.3 World Transdermal Drug Patches Pricing Trends (2018-2029)
1.3 World Transdermal Drug Patches Production by Region (Based on Production Site)
1.3.1 World Transdermal Drug Patches Production Value by Region (2018-2029)
1.3.2 World Transdermal Drug Patches Production by Region (2018-2029)
1.3.3 World Transdermal Drug Patches Average Price by Region (2018-2029)
1.3.4 North America Transdermal Drug Patches Production (2018-2029)
1.3.5 Europe Transdermal Drug Patches Production (2018-2029)
1.3.6 China Transdermal Drug Patches Production (2018-2029)
1.3.7 Japan Transdermal Drug Patches Production (2018-2029)
1.3.8 Israel Transdermal Drug Patches Production (2018-2029)
1.3.9 India Transdermal Drug Patches Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transdermal Drug Patches Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transdermal Drug Patches Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Transdermal Drug Patches Demand (2018-2029)
2.2 World Transdermal Drug Patches Consumption by Region
2.2.1 World Transdermal Drug Patches Consumption by Region (2018-2023)
2.2.2 World Transdermal Drug Patches Consumption Forecast by Region (2024-2029)
2.3 United States Transdermal Drug Patches Consumption (2018-2029)
2.4 China Transdermal Drug Patches Consumption (2018-2029)
2.5 Europe Transdermal Drug Patches Consumption (2018-2029)
2.6 Japan Transdermal Drug Patches Consumption (2018-2029)
2.7 South Korea Transdermal Drug Patches Consumption (2018-2029)
2.8 ASEAN Transdermal Drug Patches Consumption (2018-2029)
2.9 India Transdermal Drug Patches Consumption (2018-2029)

3 World Transdermal Drug Patches Manufacturers Competitive Analysis
3.1 World Transdermal Drug Patches Production Value by Manufacturer (2018-2023)
3.2 World Transdermal Drug Patches Production by Manufacturer (2018-2023)
3.3 World Transdermal Drug Patches Average Price by Manufacturer (2018-2023)
3.4 Transdermal Drug Patches Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transdermal Drug Patches Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transdermal Drug Patches in 2022
3.5.3 Global Concentration Ratios (CR8) for Transdermal Drug Patches in 2022
3.6 Transdermal Drug Patches Market: Overall Company Footprint Analysis
3.6.1 Transdermal Drug Patches Market: Region Footprint
3.6.2 Transdermal Drug Patches Market: Company Product Type Footprint
3.6.3 Transdermal Drug Patches Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Transdermal Drug Patches Production Value Comparison
4.1.1 United States VS China: Transdermal Drug Patches Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Transdermal Drug Patches Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Transdermal Drug Patches Production Comparison
4.2.1 United States VS China: Transdermal Drug Patches Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Transdermal Drug Patches Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Transdermal Drug Patches Consumption Comparison
4.3.1 United States VS China: Transdermal Drug Patches Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Transdermal Drug Patches Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Transdermal Drug Patches Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Transdermal Drug Patches Production Value (2018-2023)
4.4.3 United States Based Manufacturers Transdermal Drug Patches Production (2018-2023)
4.5 China Based Transdermal Drug Patches Manufacturers and Market Share
4.5.1 China Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Transdermal Drug Patches Production Value (2018-2023)
4.5.3 China Based Manufacturers Transdermal Drug Patches Production (2018-2023)
4.6 Rest of World Based Transdermal Drug Patches Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Transdermal Drug Patches Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Transdermal Drug Patches Production (2018-2023)

5 Market Analysis by Type
5.1 World Transdermal Drug Patches Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Methyl Salicylate-based Patch
5.2.2 Rivastigmine Transdermal Patch
5.2.3 Fentanyl Transdermal Patch
5.2.4 Lidocaine Patch
5.2.5 Diclofenac Patch
5.2.6 Nicotine Transdermal Patch
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Transdermal Drug Patches Production by Type (2018-2029)
5.3.2 World Transdermal Drug Patches Production Value by Type (2018-2029)
5.3.3 World Transdermal Drug Patches Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Transdermal Drug Patches Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Rx Channel
6.2.2 OTC Channel
6.3 Market Segment by Application
6.3.1 World Transdermal Drug Patches Production by Application (2018-2029)
6.3.2 World Transdermal Drug Patches Production Value by Application (2018-2029)
6.3.3 World Transdermal Drug Patches Average Price by Application (2018-2029)

7 Company Profiles
7.1 Hisamitsu Pharmaceutical
7.1.1 Hisamitsu Pharmaceutical Details
7.1.2 Hisamitsu Pharmaceutical Major Business
7.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
7.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
7.1.6 Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Transdermal Drug Patches Product and Services
7.2.4 Johnson & Johnson Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Mylan
7.3.1 Mylan Details
7.3.2 Mylan Major Business
7.3.3 Mylan Transdermal Drug Patches Product and Services
7.3.4 Mylan Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mylan Recent Developments/Updates
7.3.6 Mylan Competitive Strengths & Weaknesses
7.4 UCB Pharma
7.4.1 UCB Pharma Details
7.4.2 UCB Pharma Major Business
7.4.3 UCB Pharma Transdermal Drug Patches Product and Services
7.4.4 UCB Pharma Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 UCB Pharma Recent Developments/Updates
7.4.6 UCB Pharma Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Transdermal Drug Patches Product and Services
7.5.4 Novartis Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Details
7.6.2 Teva Pharmaceutical Major Business
7.6.3 Teva Pharmaceutical Transdermal Drug Patches Product and Services
7.6.4 Teva Pharmaceutical Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Teva Pharmaceutical Recent Developments/Updates
7.6.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.7 Beijing Tide Pharmaceutical
7.7.1 Beijing Tide Pharmaceutical Details
7.7.2 Beijing Tide Pharmaceutical Major Business
7.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
7.7.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7.7.6 Beijing Tide Pharmaceutical Competitive Strengths & Weaknesses
7.8 Chattem
7.8.1 Chattem Details
7.8.2 Chattem Major Business
7.8.3 Chattem Transdermal Drug Patches Product and Services
7.8.4 Chattem Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Chattem Recent Developments/Updates
7.8.6 Chattem Competitive Strengths & Weaknesses
7.9 Nitto Denko
7.9.1 Nitto Denko Details
7.9.2 Nitto Denko Major Business
7.9.3 Nitto Denko Transdermal Drug Patches Product and Services
7.9.4 Nitto Denko Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Nitto Denko Recent Developments/Updates
7.9.6 Nitto Denko Competitive Strengths & Weaknesses
7.10 Grünenthal
7.10.1 Grünenthal Details
7.10.2 Grünenthal Major Business
7.10.3 Grünenthal Transdermal Drug Patches Product and Services
7.10.4 Grünenthal Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Grünenthal Recent Developments/Updates
7.10.6 Grünenthal Competitive Strengths & Weaknesses
7.11 Mundipharma
7.11.1 Mundipharma Details
7.11.2 Mundipharma Major Business
7.11.3 Mundipharma Transdermal Drug Patches Product and Services
7.11.4 Mundipharma Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Mundipharma Recent Developments/Updates
7.11.6 Mundipharma Competitive Strengths & Weaknesses
7.12 GSK
7.12.1 GSK Details
7.12.2 GSK Major Business
7.12.3 GSK Transdermal Drug Patches Product and Services
7.12.4 GSK Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 GSK Recent Developments/Updates
7.12.6 GSK Competitive Strengths & Weaknesses
7.13 Luye Pharma Group
7.13.1 Luye Pharma Group Details
7.13.2 Luye Pharma Group Major Business
7.13.3 Luye Pharma Group Transdermal Drug Patches Product and Services
7.13.4 Luye Pharma Group Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Luye Pharma Group Recent Developments/Updates
7.13.6 Luye Pharma Group Competitive Strengths & Weaknesses
7.14 Bayer
7.14.1 Bayer Details
7.14.2 Bayer Major Business
7.14.3 Bayer Transdermal Drug Patches Product and Services
7.14.4 Bayer Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bayer Recent Developments/Updates
7.14.6 Bayer Competitive Strengths & Weaknesses
7.15 IBSA Group
7.15.1 IBSA Group Details
7.15.2 IBSA Group Major Business
7.15.3 IBSA Group Transdermal Drug Patches Product and Services
7.15.4 IBSA Group Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 IBSA Group Recent Developments/Updates
7.15.6 IBSA Group Competitive Strengths & Weaknesses
7.16 Dr Reddy’s Laboratories
7.16.1 Dr Reddy’s Laboratories Details
7.16.2 Dr Reddy’s Laboratories Major Business
7.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
7.16.4 Dr Reddy’s Laboratories Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Dr Reddy’s Laboratories Recent Developments/Updates
7.16.6 Dr Reddy’s Laboratories Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Transdermal Drug Patches Industry Chain
8.2 Transdermal Drug Patches Upstream Analysis
8.2.1 Transdermal Drug Patches Core Raw Materials
8.2.2 Main Manufacturers of Transdermal Drug Patches Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Transdermal Drug Patches Production Mode
8.6 Transdermal Drug Patches Procurement Model
8.7 Transdermal Drug Patches Industry Sales Model and Sales Channels
8.7.1 Transdermal Drug Patches Sales Model
8.7.2 Transdermal Drug Patches Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Transdermal Drug Patches Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Transdermal Drug Patches Production Value by Region (2018-2023) & (USD Million)
Table 3. World Transdermal Drug Patches Production Value by Region (2024-2029) & (USD Million)
Table 4. World Transdermal Drug Patches Production Value Market Share by Region (2018-2023)
Table 5. World Transdermal Drug Patches Production Value Market Share by Region (2024-2029)
Table 6. World Transdermal Drug Patches Production by Region (2018-2023) & (M Pieces)
Table 7. World Transdermal Drug Patches Production by Region (2024-2029) & (M Pieces)
Table 8. World Transdermal Drug Patches Production Market Share by Region (2018-2023)
Table 9. World Transdermal Drug Patches Production Market Share by Region (2024-2029)
Table 10. World Transdermal Drug Patches Average Price by Region (2018-2023) & (USD/Piece)
Table 11. World Transdermal Drug Patches Average Price by Region (2024-2029) & (USD/Piece)
Table 12. Transdermal Drug Patches Major Market Trends
Table 13. World Transdermal Drug Patches Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Pieces)
Table 14. World Transdermal Drug Patches Consumption by Region (2018-2023) & (M Pieces)
Table 15. World Transdermal Drug Patches Consumption Forecast by Region (2024-2029) & (M Pieces)
Table 16. World Transdermal Drug Patches Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Transdermal Drug Patches Producers in 2022
Table 18. World Transdermal Drug Patches Production by Manufacturer (2018-2023) & (M Pieces)
Table 19. Production Market Share of Key Transdermal Drug Patches Producers in 2022
Table 20. World Transdermal Drug Patches Average Price by Manufacturer (2018-2023) & (USD/Piece)
Table 21. Global Transdermal Drug Patches Company Evaluation Quadrant
Table 22. World Transdermal Drug Patches Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Transdermal Drug Patches Production Site of Key Manufacturer
Table 24. Transdermal Drug Patches Market: Company Product Type Footprint
Table 25. Transdermal Drug Patches Market: Company Product Application Footprint
Table 26. Transdermal Drug Patches Competitive Factors
Table 27. Transdermal Drug Patches New Entrant and Capacity Expansion Plans
Table 28. Transdermal Drug Patches Mergers & Acquisitions Activity
Table 29. United States VS China Transdermal Drug Patches Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Transdermal Drug Patches Production Comparison, (2018 & 2022 & 2029) & (M Pieces)
Table 31. United States VS China Transdermal Drug Patches Consumption Comparison, (2018 & 2022 & 2029) & (M Pieces)
Table 32. United States Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transdermal Drug Patches Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Transdermal Drug Patches Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Transdermal Drug Patches Production (2018-2023) & (M Pieces)
Table 36. United States Based Manufacturers Transdermal Drug Patches Production Market Share (2018-2023)
Table 37. China Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transdermal Drug Patches Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Transdermal Drug Patches Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Transdermal Drug Patches Production (2018-2023) & (M Pieces)
Table 41. China Based Manufacturers Transdermal Drug Patches Production Market Share (2018-2023)
Table 42. Rest of World Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Transdermal Drug Patches Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Transdermal Drug Patches Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Transdermal Drug Patches Production (2018-2023) & (M Pieces)
Table 46. Rest of World Based Manufacturers Transdermal Drug Patches Production Market Share (2018-2023)
Table 47. World Transdermal Drug Patches Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Transdermal Drug Patches Production by Type (2018-2023) & (M Pieces)
Table 49. World Transdermal Drug Patches Production by Type (2024-2029) & (M Pieces)
Table 50. World Transdermal Drug Patches Production Value by Type (2018-2023) & (USD Million)
Table 51. World Transdermal Drug Patches Production Value by Type (2024-2029) & (USD Million)
Table 52. World Transdermal Drug Patches Average Price by Type (2018-2023) & (USD/Piece)
Table 53. World Transdermal Drug Patches Average Price by Type (2024-2029) & (USD/Piece)
Table 54. World Transdermal Drug Patches Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Transdermal Drug Patches Production by Application (2018-2023) & (M Pieces)
Table 56. World Transdermal Drug Patches Production by Application (2024-2029) & (M Pieces)
Table 57. World Transdermal Drug Patches Production Value by Application (2018-2023) & (USD Million)
Table 58. World Transdermal Drug Patches Production Value by Application (2024-2029) & (USD Million)
Table 59. World Transdermal Drug Patches Average Price by Application (2018-2023) & (USD/Piece)
Table 60. World Transdermal Drug Patches Average Price by Application (2024-2029) & (USD/Piece)
Table 61. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Hisamitsu Pharmaceutical Major Business
Table 63. Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
Table 64. Hisamitsu Pharmaceutical Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 66. Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Transdermal Drug Patches Product and Services
Table 70. Johnson & Johnson Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
Table 73. Mylan Basic Information, Manufacturing Base and Competitors
Table 74. Mylan Major Business
Table 75. Mylan Transdermal Drug Patches Product and Services
Table 76. Mylan Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mylan Recent Developments/Updates
Table 78. Mylan Competitive Strengths & Weaknesses
Table 79. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 80. UCB Pharma Major Business
Table 81. UCB Pharma Transdermal Drug Patches Product and Services
Table 82. UCB Pharma Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. UCB Pharma Recent Developments/Updates
Table 84. UCB Pharma Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Transdermal Drug Patches Product and Services
Table 88. Novartis Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Teva Pharmaceutical Major Business
Table 93. Teva Pharmaceutical Transdermal Drug Patches Product and Services
Table 94. Teva Pharmaceutical Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Teva Pharmaceutical Recent Developments/Updates
Table 96. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Beijing Tide Pharmaceutical Major Business
Table 99. Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
Table 100. Beijing Tide Pharmaceutical Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 102. Beijing Tide Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Chattem Basic Information, Manufacturing Base and Competitors
Table 104. Chattem Major Business
Table 105. Chattem Transdermal Drug Patches Product and Services
Table 106. Chattem Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Chattem Recent Developments/Updates
Table 108. Chattem Competitive Strengths & Weaknesses
Table 109. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 110. Nitto Denko Major Business
Table 111. Nitto Denko Transdermal Drug Patches Product and Services
Table 112. Nitto Denko Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Nitto Denko Recent Developments/Updates
Table 114. Nitto Denko Competitive Strengths & Weaknesses
Table 115. Grünenthal Basic Information, Manufacturing Base and Competitors
Table 116. Grünenthal Major Business
Table 117. Grünenthal Transdermal Drug Patches Product and Services
Table 118. Grünenthal Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Grünenthal Recent Developments/Updates
Table 120. Grünenthal Competitive Strengths & Weaknesses
Table 121. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 122. Mundipharma Major Business
Table 123. Mundipharma Transdermal Drug Patches Product and Services
Table 124. Mundipharma Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Mundipharma Recent Developments/Updates
Table 126. Mundipharma Competitive Strengths & Weaknesses
Table 127. GSK Basic Information, Manufacturing Base and Competitors
Table 128. GSK Major Business
Table 129. GSK Transdermal Drug Patches Product and Services
Table 130. GSK Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. GSK Recent Developments/Updates
Table 132. GSK Competitive Strengths & Weaknesses
Table 133. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 134. Luye Pharma Group Major Business
Table 135. Luye Pharma Group Transdermal Drug Patches Product and Services
Table 136. Luye Pharma Group Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Luye Pharma Group Recent Developments/Updates
Table 138. Luye Pharma Group Competitive Strengths & Weaknesses
Table 139. Bayer Basic Information, Manufacturing Base and Competitors
Table 140. Bayer Major Business
Table 141. Bayer Transdermal Drug Patches Product and Services
Table 142. Bayer Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bayer Recent Developments/Updates
Table 144. Bayer Competitive Strengths & Weaknesses
Table 145. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 146. IBSA Group Major Business
Table 147. IBSA Group Transdermal Drug Patches Product and Services
Table 148. IBSA Group Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. IBSA Group Recent Developments/Updates
Table 150. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 151. Dr Reddy’s Laboratories Major Business
Table 152. Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
Table 153. Dr Reddy’s Laboratories Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Transdermal Drug Patches Upstream (Raw Materials)
Table 155. Transdermal Drug Patches Typical Customers
Table 156. Transdermal Drug Patches Typical Distributors
List of Figure
Figure 1. Transdermal Drug Patches Picture
Figure 2. World Transdermal Drug Patches Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Transdermal Drug Patches Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 5. World Transdermal Drug Patches Average Price (2018-2029) & (USD/Piece)
Figure 6. World Transdermal Drug Patches Production Value Market Share by Region (2018-2029)
Figure 7. World Transdermal Drug Patches Production Market Share by Region (2018-2029)
Figure 8. North America Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 9. Europe Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 10. China Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 11. Japan Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 12. Israel Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 13. India Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 14. Transdermal Drug Patches Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 17. World Transdermal Drug Patches Consumption Market Share by Region (2018-2029)
Figure 18. United States Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 19. China Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 20. Europe Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 21. Japan Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 22. South Korea Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 23. ASEAN Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 24. India Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 25. Producer Shipments of Transdermal Drug Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 26. Global Four-firm Concentration Ratios (CR4) for Transdermal Drug Patches Markets in 2022
Figure 27. Global Four-firm Concentration Ratios (CR8) for Transdermal Drug Patches Markets in 2022
Figure 28. United States VS China: Transdermal Drug Patches Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States VS China: Transdermal Drug Patches Production Market Share Comparison (2018 & 2022 & 2029)
Figure 30. United States VS China: Transdermal Drug Patches Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 31. United States Based Manufacturers Transdermal Drug Patches Production Market Share 2022
Figure 32. China Based Manufacturers Transdermal Drug Patches Production Market Share 2022
Figure 33. Rest of World Based Manufacturers Transdermal Drug Patches Production Market Share 2022
Figure 34. World Transdermal Drug Patches Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 35. World Transdermal Drug Patches Production Value Market Share by Type in 2022
Figure 36. Methyl Salicylate-based Patch
Figure 37. Rivastigmine Transdermal Patch
Figure 38. Fentanyl Transdermal Patch
Figure 39. Lidocaine Patch
Figure 40. Diclofenac Patch
Figure 41. Nicotine Transdermal Patch
Figure 42. Others
Figure 43. World Transdermal Drug Patches Production Market Share by Type (2018-2029)
Figure 44. World Transdermal Drug Patches Production Value Market Share by Type (2018-2029)
Figure 45. World Transdermal Drug Patches Average Price by Type (2018-2029) & (USD/Piece)
Figure 46. World Transdermal Drug Patches Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 47. World Transdermal Drug Patches Production Value Market Share by Application in 2022
Figure 48. Rx Channel
Figure 49. OTC Channel
Figure 50. World Transdermal Drug Patches Production Market Share by Application (2018-2029)
Figure 51. World Transdermal Drug Patches Production Value Market Share by Application (2018-2029)
Figure 52. World Transdermal Drug Patches Average Price by Application (2018-2029) & (USD/Piece)
Figure 53. Transdermal Drug Patches Industry Chain
Figure 54. Transdermal Drug Patches Procurement Model
Figure 55. Transdermal Drug Patches Sales Model
Figure 56. Transdermal Drug Patches Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Transdermal Drug Patches Supply, Demand and Key Producers, 2023-2029

Global Transdermal Drug Patches Supply, Demand and Key Producers, 2023-2029

Page: 119

Published Date: 12 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Transdermal Drug Patches market size is expected to reach $ 7952.9 million by 2029, rising at a market growth of 1.8% CAGR during the forecast period (2023-2029).

Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

This report studies the global Transdermal Drug Patches production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Transdermal Drug Patches, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transdermal Drug Patches that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Transdermal Drug Patches total production and demand, 2018-2029, (M Pieces)
Global Transdermal Drug Patches total production value, 2018-2029, (USD Million)
Global Transdermal Drug Patches production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Pieces)
Global Transdermal Drug Patches consumption by region & country, CAGR, 2018-2029 & (M Pieces)
U.S. VS China: Transdermal Drug Patches domestic production, consumption, key domestic manufacturers and share
Global Transdermal Drug Patches production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Pieces)
Global Transdermal Drug Patches production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Pieces)
Global Transdermal Drug Patches production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Pieces)
This reports profiles key players in the global Transdermal Drug Patches market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem and Nitto Denko, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transdermal Drug Patches market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Pieces) and average price (USD/Piece) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Transdermal Drug Patches Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Transdermal Drug Patches Market, Segmentation by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Global Transdermal Drug Patches Market, Segmentation by Application
Rx Channel
OTC Channel

Companies Profiled:
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories

Key Questions Answered
1. How big is the global Transdermal Drug Patches market?
2. What is the demand of the global Transdermal Drug Patches market?
3. What is the year over year growth of the global Transdermal Drug Patches market?
4. What is the production and production value of the global Transdermal Drug Patches market?
5. Who are the key producers in the global Transdermal Drug Patches market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Transdermal Drug Patches Introduction
1.2 World Transdermal Drug Patches Supply & Forecast
1.2.1 World Transdermal Drug Patches Production Value (2018 & 2022 & 2029)
1.2.2 World Transdermal Drug Patches Production (2018-2029)
1.2.3 World Transdermal Drug Patches Pricing Trends (2018-2029)
1.3 World Transdermal Drug Patches Production by Region (Based on Production Site)
1.3.1 World Transdermal Drug Patches Production Value by Region (2018-2029)
1.3.2 World Transdermal Drug Patches Production by Region (2018-2029)
1.3.3 World Transdermal Drug Patches Average Price by Region (2018-2029)
1.3.4 North America Transdermal Drug Patches Production (2018-2029)
1.3.5 Europe Transdermal Drug Patches Production (2018-2029)
1.3.6 China Transdermal Drug Patches Production (2018-2029)
1.3.7 Japan Transdermal Drug Patches Production (2018-2029)
1.3.8 Israel Transdermal Drug Patches Production (2018-2029)
1.3.9 India Transdermal Drug Patches Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transdermal Drug Patches Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transdermal Drug Patches Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Transdermal Drug Patches Demand (2018-2029)
2.2 World Transdermal Drug Patches Consumption by Region
2.2.1 World Transdermal Drug Patches Consumption by Region (2018-2023)
2.2.2 World Transdermal Drug Patches Consumption Forecast by Region (2024-2029)
2.3 United States Transdermal Drug Patches Consumption (2018-2029)
2.4 China Transdermal Drug Patches Consumption (2018-2029)
2.5 Europe Transdermal Drug Patches Consumption (2018-2029)
2.6 Japan Transdermal Drug Patches Consumption (2018-2029)
2.7 South Korea Transdermal Drug Patches Consumption (2018-2029)
2.8 ASEAN Transdermal Drug Patches Consumption (2018-2029)
2.9 India Transdermal Drug Patches Consumption (2018-2029)

3 World Transdermal Drug Patches Manufacturers Competitive Analysis
3.1 World Transdermal Drug Patches Production Value by Manufacturer (2018-2023)
3.2 World Transdermal Drug Patches Production by Manufacturer (2018-2023)
3.3 World Transdermal Drug Patches Average Price by Manufacturer (2018-2023)
3.4 Transdermal Drug Patches Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transdermal Drug Patches Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transdermal Drug Patches in 2022
3.5.3 Global Concentration Ratios (CR8) for Transdermal Drug Patches in 2022
3.6 Transdermal Drug Patches Market: Overall Company Footprint Analysis
3.6.1 Transdermal Drug Patches Market: Region Footprint
3.6.2 Transdermal Drug Patches Market: Company Product Type Footprint
3.6.3 Transdermal Drug Patches Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Transdermal Drug Patches Production Value Comparison
4.1.1 United States VS China: Transdermal Drug Patches Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Transdermal Drug Patches Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Transdermal Drug Patches Production Comparison
4.2.1 United States VS China: Transdermal Drug Patches Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Transdermal Drug Patches Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Transdermal Drug Patches Consumption Comparison
4.3.1 United States VS China: Transdermal Drug Patches Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Transdermal Drug Patches Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Transdermal Drug Patches Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Transdermal Drug Patches Production Value (2018-2023)
4.4.3 United States Based Manufacturers Transdermal Drug Patches Production (2018-2023)
4.5 China Based Transdermal Drug Patches Manufacturers and Market Share
4.5.1 China Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Transdermal Drug Patches Production Value (2018-2023)
4.5.3 China Based Manufacturers Transdermal Drug Patches Production (2018-2023)
4.6 Rest of World Based Transdermal Drug Patches Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Transdermal Drug Patches Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Transdermal Drug Patches Production (2018-2023)

5 Market Analysis by Type
5.1 World Transdermal Drug Patches Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Methyl Salicylate-based Patch
5.2.2 Rivastigmine Transdermal Patch
5.2.3 Fentanyl Transdermal Patch
5.2.4 Lidocaine Patch
5.2.5 Diclofenac Patch
5.2.6 Nicotine Transdermal Patch
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Transdermal Drug Patches Production by Type (2018-2029)
5.3.2 World Transdermal Drug Patches Production Value by Type (2018-2029)
5.3.3 World Transdermal Drug Patches Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Transdermal Drug Patches Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Rx Channel
6.2.2 OTC Channel
6.3 Market Segment by Application
6.3.1 World Transdermal Drug Patches Production by Application (2018-2029)
6.3.2 World Transdermal Drug Patches Production Value by Application (2018-2029)
6.3.3 World Transdermal Drug Patches Average Price by Application (2018-2029)

7 Company Profiles
7.1 Hisamitsu Pharmaceutical
7.1.1 Hisamitsu Pharmaceutical Details
7.1.2 Hisamitsu Pharmaceutical Major Business
7.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
7.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
7.1.6 Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Transdermal Drug Patches Product and Services
7.2.4 Johnson & Johnson Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Mylan
7.3.1 Mylan Details
7.3.2 Mylan Major Business
7.3.3 Mylan Transdermal Drug Patches Product and Services
7.3.4 Mylan Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mylan Recent Developments/Updates
7.3.6 Mylan Competitive Strengths & Weaknesses
7.4 UCB Pharma
7.4.1 UCB Pharma Details
7.4.2 UCB Pharma Major Business
7.4.3 UCB Pharma Transdermal Drug Patches Product and Services
7.4.4 UCB Pharma Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 UCB Pharma Recent Developments/Updates
7.4.6 UCB Pharma Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Transdermal Drug Patches Product and Services
7.5.4 Novartis Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Details
7.6.2 Teva Pharmaceutical Major Business
7.6.3 Teva Pharmaceutical Transdermal Drug Patches Product and Services
7.6.4 Teva Pharmaceutical Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Teva Pharmaceutical Recent Developments/Updates
7.6.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.7 Beijing Tide Pharmaceutical
7.7.1 Beijing Tide Pharmaceutical Details
7.7.2 Beijing Tide Pharmaceutical Major Business
7.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
7.7.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7.7.6 Beijing Tide Pharmaceutical Competitive Strengths & Weaknesses
7.8 Chattem
7.8.1 Chattem Details
7.8.2 Chattem Major Business
7.8.3 Chattem Transdermal Drug Patches Product and Services
7.8.4 Chattem Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Chattem Recent Developments/Updates
7.8.6 Chattem Competitive Strengths & Weaknesses
7.9 Nitto Denko
7.9.1 Nitto Denko Details
7.9.2 Nitto Denko Major Business
7.9.3 Nitto Denko Transdermal Drug Patches Product and Services
7.9.4 Nitto Denko Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Nitto Denko Recent Developments/Updates
7.9.6 Nitto Denko Competitive Strengths & Weaknesses
7.10 Grünenthal
7.10.1 Grünenthal Details
7.10.2 Grünenthal Major Business
7.10.3 Grünenthal Transdermal Drug Patches Product and Services
7.10.4 Grünenthal Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Grünenthal Recent Developments/Updates
7.10.6 Grünenthal Competitive Strengths & Weaknesses
7.11 Mundipharma
7.11.1 Mundipharma Details
7.11.2 Mundipharma Major Business
7.11.3 Mundipharma Transdermal Drug Patches Product and Services
7.11.4 Mundipharma Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Mundipharma Recent Developments/Updates
7.11.6 Mundipharma Competitive Strengths & Weaknesses
7.12 GSK
7.12.1 GSK Details
7.12.2 GSK Major Business
7.12.3 GSK Transdermal Drug Patches Product and Services
7.12.4 GSK Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 GSK Recent Developments/Updates
7.12.6 GSK Competitive Strengths & Weaknesses
7.13 Luye Pharma Group
7.13.1 Luye Pharma Group Details
7.13.2 Luye Pharma Group Major Business
7.13.3 Luye Pharma Group Transdermal Drug Patches Product and Services
7.13.4 Luye Pharma Group Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Luye Pharma Group Recent Developments/Updates
7.13.6 Luye Pharma Group Competitive Strengths & Weaknesses
7.14 Bayer
7.14.1 Bayer Details
7.14.2 Bayer Major Business
7.14.3 Bayer Transdermal Drug Patches Product and Services
7.14.4 Bayer Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bayer Recent Developments/Updates
7.14.6 Bayer Competitive Strengths & Weaknesses
7.15 IBSA Group
7.15.1 IBSA Group Details
7.15.2 IBSA Group Major Business
7.15.3 IBSA Group Transdermal Drug Patches Product and Services
7.15.4 IBSA Group Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 IBSA Group Recent Developments/Updates
7.15.6 IBSA Group Competitive Strengths & Weaknesses
7.16 Dr Reddy’s Laboratories
7.16.1 Dr Reddy’s Laboratories Details
7.16.2 Dr Reddy’s Laboratories Major Business
7.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
7.16.4 Dr Reddy’s Laboratories Transdermal Drug Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Dr Reddy’s Laboratories Recent Developments/Updates
7.16.6 Dr Reddy’s Laboratories Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Transdermal Drug Patches Industry Chain
8.2 Transdermal Drug Patches Upstream Analysis
8.2.1 Transdermal Drug Patches Core Raw Materials
8.2.2 Main Manufacturers of Transdermal Drug Patches Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Transdermal Drug Patches Production Mode
8.6 Transdermal Drug Patches Procurement Model
8.7 Transdermal Drug Patches Industry Sales Model and Sales Channels
8.7.1 Transdermal Drug Patches Sales Model
8.7.2 Transdermal Drug Patches Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Transdermal Drug Patches Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Transdermal Drug Patches Production Value by Region (2018-2023) & (USD Million)
Table 3. World Transdermal Drug Patches Production Value by Region (2024-2029) & (USD Million)
Table 4. World Transdermal Drug Patches Production Value Market Share by Region (2018-2023)
Table 5. World Transdermal Drug Patches Production Value Market Share by Region (2024-2029)
Table 6. World Transdermal Drug Patches Production by Region (2018-2023) & (M Pieces)
Table 7. World Transdermal Drug Patches Production by Region (2024-2029) & (M Pieces)
Table 8. World Transdermal Drug Patches Production Market Share by Region (2018-2023)
Table 9. World Transdermal Drug Patches Production Market Share by Region (2024-2029)
Table 10. World Transdermal Drug Patches Average Price by Region (2018-2023) & (USD/Piece)
Table 11. World Transdermal Drug Patches Average Price by Region (2024-2029) & (USD/Piece)
Table 12. Transdermal Drug Patches Major Market Trends
Table 13. World Transdermal Drug Patches Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Pieces)
Table 14. World Transdermal Drug Patches Consumption by Region (2018-2023) & (M Pieces)
Table 15. World Transdermal Drug Patches Consumption Forecast by Region (2024-2029) & (M Pieces)
Table 16. World Transdermal Drug Patches Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Transdermal Drug Patches Producers in 2022
Table 18. World Transdermal Drug Patches Production by Manufacturer (2018-2023) & (M Pieces)
Table 19. Production Market Share of Key Transdermal Drug Patches Producers in 2022
Table 20. World Transdermal Drug Patches Average Price by Manufacturer (2018-2023) & (USD/Piece)
Table 21. Global Transdermal Drug Patches Company Evaluation Quadrant
Table 22. World Transdermal Drug Patches Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Transdermal Drug Patches Production Site of Key Manufacturer
Table 24. Transdermal Drug Patches Market: Company Product Type Footprint
Table 25. Transdermal Drug Patches Market: Company Product Application Footprint
Table 26. Transdermal Drug Patches Competitive Factors
Table 27. Transdermal Drug Patches New Entrant and Capacity Expansion Plans
Table 28. Transdermal Drug Patches Mergers & Acquisitions Activity
Table 29. United States VS China Transdermal Drug Patches Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Transdermal Drug Patches Production Comparison, (2018 & 2022 & 2029) & (M Pieces)
Table 31. United States VS China Transdermal Drug Patches Consumption Comparison, (2018 & 2022 & 2029) & (M Pieces)
Table 32. United States Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transdermal Drug Patches Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Transdermal Drug Patches Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Transdermal Drug Patches Production (2018-2023) & (M Pieces)
Table 36. United States Based Manufacturers Transdermal Drug Patches Production Market Share (2018-2023)
Table 37. China Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transdermal Drug Patches Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Transdermal Drug Patches Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Transdermal Drug Patches Production (2018-2023) & (M Pieces)
Table 41. China Based Manufacturers Transdermal Drug Patches Production Market Share (2018-2023)
Table 42. Rest of World Based Transdermal Drug Patches Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Transdermal Drug Patches Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Transdermal Drug Patches Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Transdermal Drug Patches Production (2018-2023) & (M Pieces)
Table 46. Rest of World Based Manufacturers Transdermal Drug Patches Production Market Share (2018-2023)
Table 47. World Transdermal Drug Patches Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Transdermal Drug Patches Production by Type (2018-2023) & (M Pieces)
Table 49. World Transdermal Drug Patches Production by Type (2024-2029) & (M Pieces)
Table 50. World Transdermal Drug Patches Production Value by Type (2018-2023) & (USD Million)
Table 51. World Transdermal Drug Patches Production Value by Type (2024-2029) & (USD Million)
Table 52. World Transdermal Drug Patches Average Price by Type (2018-2023) & (USD/Piece)
Table 53. World Transdermal Drug Patches Average Price by Type (2024-2029) & (USD/Piece)
Table 54. World Transdermal Drug Patches Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Transdermal Drug Patches Production by Application (2018-2023) & (M Pieces)
Table 56. World Transdermal Drug Patches Production by Application (2024-2029) & (M Pieces)
Table 57. World Transdermal Drug Patches Production Value by Application (2018-2023) & (USD Million)
Table 58. World Transdermal Drug Patches Production Value by Application (2024-2029) & (USD Million)
Table 59. World Transdermal Drug Patches Average Price by Application (2018-2023) & (USD/Piece)
Table 60. World Transdermal Drug Patches Average Price by Application (2024-2029) & (USD/Piece)
Table 61. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Hisamitsu Pharmaceutical Major Business
Table 63. Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
Table 64. Hisamitsu Pharmaceutical Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 66. Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Transdermal Drug Patches Product and Services
Table 70. Johnson & Johnson Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
Table 73. Mylan Basic Information, Manufacturing Base and Competitors
Table 74. Mylan Major Business
Table 75. Mylan Transdermal Drug Patches Product and Services
Table 76. Mylan Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mylan Recent Developments/Updates
Table 78. Mylan Competitive Strengths & Weaknesses
Table 79. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 80. UCB Pharma Major Business
Table 81. UCB Pharma Transdermal Drug Patches Product and Services
Table 82. UCB Pharma Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. UCB Pharma Recent Developments/Updates
Table 84. UCB Pharma Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Transdermal Drug Patches Product and Services
Table 88. Novartis Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Teva Pharmaceutical Major Business
Table 93. Teva Pharmaceutical Transdermal Drug Patches Product and Services
Table 94. Teva Pharmaceutical Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Teva Pharmaceutical Recent Developments/Updates
Table 96. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Beijing Tide Pharmaceutical Major Business
Table 99. Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
Table 100. Beijing Tide Pharmaceutical Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 102. Beijing Tide Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Chattem Basic Information, Manufacturing Base and Competitors
Table 104. Chattem Major Business
Table 105. Chattem Transdermal Drug Patches Product and Services
Table 106. Chattem Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Chattem Recent Developments/Updates
Table 108. Chattem Competitive Strengths & Weaknesses
Table 109. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 110. Nitto Denko Major Business
Table 111. Nitto Denko Transdermal Drug Patches Product and Services
Table 112. Nitto Denko Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Nitto Denko Recent Developments/Updates
Table 114. Nitto Denko Competitive Strengths & Weaknesses
Table 115. Grünenthal Basic Information, Manufacturing Base and Competitors
Table 116. Grünenthal Major Business
Table 117. Grünenthal Transdermal Drug Patches Product and Services
Table 118. Grünenthal Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Grünenthal Recent Developments/Updates
Table 120. Grünenthal Competitive Strengths & Weaknesses
Table 121. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 122. Mundipharma Major Business
Table 123. Mundipharma Transdermal Drug Patches Product and Services
Table 124. Mundipharma Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Mundipharma Recent Developments/Updates
Table 126. Mundipharma Competitive Strengths & Weaknesses
Table 127. GSK Basic Information, Manufacturing Base and Competitors
Table 128. GSK Major Business
Table 129. GSK Transdermal Drug Patches Product and Services
Table 130. GSK Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. GSK Recent Developments/Updates
Table 132. GSK Competitive Strengths & Weaknesses
Table 133. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 134. Luye Pharma Group Major Business
Table 135. Luye Pharma Group Transdermal Drug Patches Product and Services
Table 136. Luye Pharma Group Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Luye Pharma Group Recent Developments/Updates
Table 138. Luye Pharma Group Competitive Strengths & Weaknesses
Table 139. Bayer Basic Information, Manufacturing Base and Competitors
Table 140. Bayer Major Business
Table 141. Bayer Transdermal Drug Patches Product and Services
Table 142. Bayer Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bayer Recent Developments/Updates
Table 144. Bayer Competitive Strengths & Weaknesses
Table 145. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 146. IBSA Group Major Business
Table 147. IBSA Group Transdermal Drug Patches Product and Services
Table 148. IBSA Group Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. IBSA Group Recent Developments/Updates
Table 150. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 151. Dr Reddy’s Laboratories Major Business
Table 152. Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
Table 153. Dr Reddy’s Laboratories Transdermal Drug Patches Production (M Pieces), Price (USD/Piece), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Transdermal Drug Patches Upstream (Raw Materials)
Table 155. Transdermal Drug Patches Typical Customers
Table 156. Transdermal Drug Patches Typical Distributors
List of Figure
Figure 1. Transdermal Drug Patches Picture
Figure 2. World Transdermal Drug Patches Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Transdermal Drug Patches Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 5. World Transdermal Drug Patches Average Price (2018-2029) & (USD/Piece)
Figure 6. World Transdermal Drug Patches Production Value Market Share by Region (2018-2029)
Figure 7. World Transdermal Drug Patches Production Market Share by Region (2018-2029)
Figure 8. North America Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 9. Europe Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 10. China Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 11. Japan Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 12. Israel Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 13. India Transdermal Drug Patches Production (2018-2029) & (M Pieces)
Figure 14. Transdermal Drug Patches Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 17. World Transdermal Drug Patches Consumption Market Share by Region (2018-2029)
Figure 18. United States Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 19. China Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 20. Europe Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 21. Japan Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 22. South Korea Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 23. ASEAN Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 24. India Transdermal Drug Patches Consumption (2018-2029) & (M Pieces)
Figure 25. Producer Shipments of Transdermal Drug Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 26. Global Four-firm Concentration Ratios (CR4) for Transdermal Drug Patches Markets in 2022
Figure 27. Global Four-firm Concentration Ratios (CR8) for Transdermal Drug Patches Markets in 2022
Figure 28. United States VS China: Transdermal Drug Patches Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States VS China: Transdermal Drug Patches Production Market Share Comparison (2018 & 2022 & 2029)
Figure 30. United States VS China: Transdermal Drug Patches Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 31. United States Based Manufacturers Transdermal Drug Patches Production Market Share 2022
Figure 32. China Based Manufacturers Transdermal Drug Patches Production Market Share 2022
Figure 33. Rest of World Based Manufacturers Transdermal Drug Patches Production Market Share 2022
Figure 34. World Transdermal Drug Patches Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 35. World Transdermal Drug Patches Production Value Market Share by Type in 2022
Figure 36. Methyl Salicylate-based Patch
Figure 37. Rivastigmine Transdermal Patch
Figure 38. Fentanyl Transdermal Patch
Figure 39. Lidocaine Patch
Figure 40. Diclofenac Patch
Figure 41. Nicotine Transdermal Patch
Figure 42. Others
Figure 43. World Transdermal Drug Patches Production Market Share by Type (2018-2029)
Figure 44. World Transdermal Drug Patches Production Value Market Share by Type (2018-2029)
Figure 45. World Transdermal Drug Patches Average Price by Type (2018-2029) & (USD/Piece)
Figure 46. World Transdermal Drug Patches Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 47. World Transdermal Drug Patches Production Value Market Share by Application in 2022
Figure 48. Rx Channel
Figure 49. OTC Channel
Figure 50. World Transdermal Drug Patches Production Market Share by Application (2018-2029)
Figure 51. World Transdermal Drug Patches Production Value Market Share by Application (2018-2029)
Figure 52. World Transdermal Drug Patches Average Price by Application (2018-2029) & (USD/Piece)
Figure 53. Transdermal Drug Patches Industry Chain
Figure 54. Transdermal Drug Patches Procurement Model
Figure 55. Transdermal Drug Patches Sales Model
Figure 56. Transdermal Drug Patches Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now